News & blog

Turning lung cancer policy into action at WCLC 2026

At this year’s World Conference on Lung Cancer (WCLC), the Network will host two sessions designed bridge this gap: one focused on the skills needed to influence policy, and the other on the financing and delivery of lung cancer priorities in practice.

Delays in lung cancer care addressed in new policy brief on timed targets

Timed targets set time frames for diagnosis, treatment and other aspects of care, and are a practical way to improve outcomes and accountability.

A radiology-led model for LDCT in Norway: the first pilot programme

Norway’s pilot programme stands out for its radiology-led model, which substantially reduced the workload for respiratory services.

Webinar to examine the role of timed targets in improving lung cancer care

At our free webinar on Monday 13 July, a global panel of clinicians, professors and patient advocates will share their perspectives on how timed targets can support better, more equitable lung cancer care.

Insights from the 79th World Health Assembly

The Network joined global health leaders at the 79th World Health Assembly in May to advance a shared priority: translating growing political ambition on lung cancer into measurable, system-wide progress

From commitment to action: what has changed a year after the WHO lung health resolution?

To shift from political recognition to measurable improvement for patients, countries need to adopt an implementation‑oriented approach.

England’s lung cancer screening programme: lessons from a national roll-out

A new article in Nature Medicine presents findings from the first five years of the NHS screening programme for lung cancer in England, and the results are striking.

Reflections from LuCE’s inaugural conference

Last month, the Network attended the inaugural Lung Cancer Europe conference in Vienna, which focused on the power of co‑creation in advocacy.

Lung cancer: the looming economic crisis governments can’t ignore

Lung cancer carries a heavy cost – not only for the people diagnosed,  but for health systems and economies alike.

Beyond lung cancer: how LDCT screening could reshape early detection

Health systems are under growing strain. The challenge is no longer simply how to treat illness, but how to detect it earlier and manage it more efficiently.

Insights from the I-ELCAP 3rd Annual AGILEᴰˣᴿˣ meeting

In March, the Network attended the International Early Lung Cancer Action Program 3rd Annual AGILEᴰˣᴿˣ meeting in Gdańsk, Poland.

Advancing equity in lung cancer diagnosis: lessons from Ontario’s screening programme

We examine how the Ontario Lung Screening Program tackles health inequities by focusing on people who are historically underserved or disproportionately affected by lung cancer.